MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-GJ-24-0011155
Eshyasi Pharma Limited - pharma in Vadodara, Gujarat, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹3.66 Cr
▼ 7% YoY
Net profit · FY 2024
₹16.31 Lakh
Net margin 4.5%
EBITDA · FY 2024
₹60.33 Lakh
EBITDA margin 16.5%
Authorised capital
₹50 Lakh
Registered with MCA
Paid-up capital
₹50 Lakh
Issued & subscribed
Open charges
₹15.69 Lakh
Satisfied ₹1.95 Cr
Company age
18 yrs
Est. 2008
Employees · EPFO
2
Provident fund records
About Eshyasi Pharma Limited
Data last updated:
Eshyasi Pharma Limited is a public limited company based in Vadodara, Gujarat, India. It operates in the API manufacturers segment of the pharmaceuticals sector. It was incorporated on 04 February 2008 and has been in existence for over 18 years.
The company is registered with the Registrar of Companies (ROC), Ahmedabad, under CIN U24232GJ2008PLC052796. Its GSTIN is 24AADCT0137D1ZY (Gujarat). The company holds 2 GST registrations, all of them active.
The company has an authorised share capital of ₹50 Lakh and a paid-up capital of ₹50 Lakh. It was formerly known as Tonira Chemical Company Limited. It is led by directors including Mahesh Natvarlal Shah (Whole-Time Director) and Monik Mahesh Shah (Whole-Time Director).
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at B – 7 # 31 32 33 Krishna Industrial Estate Opposite Bidc Gorwa, Vadodara, Gujarat, India – 390016.
As per the financials filed for FY 2024, the company reported a revenue of ₹3.66 Cr, a decline of 7% compared to the previous year. For the same year it recorded a net profit of ₹16.31 Lakh (net margin 4.5%) and EBITDA of ₹60.33 Lakh (EBITDA margin 16.5%). Revenue has declined at a compounded annual rate (CAGR) of 21% over three years and 9% over five years.
The company has about 2 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Eshyasi Pharma Limited. As per MCA filings, the company has open charges of ₹15.69 Lakh and satisfied charges of ₹1.95 Cr on record. Court records list 6 cases involving the company, including 4 filed by the company and 2 filed against it; 1 case is pending.
Eshyasi Pharma Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-GJ-24-0011155). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website eshyasi.com.
Company details
CIN U24232GJ2008PLC052796
Registration Number 052796
Incorporation Date 04 February 2008
ROC Ahmedabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-GJ-24-0011155
Key People
Mahesh Natvarlal Shah Whole-Time Director Monik Mahesh Shah Whole-Time Director Shachi Monik Shah Director Recognitions & Rankings of Eshyasi Pharma
Contact details
Eshyasi Pharma Limited's registered office is in Vadodara, Gujarat. Its website is eshyasi.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressB – 7 # 31 32 33 Krishna Industrial Estate Opposite Bidc Gorwa, Vadodara, Gujarat, India – 390016
- IndustryPharma, API Manufacturers, Drug Formulation & Development
To see the full contact details of Eshyasi Pharma Limited, buy the company report.
Comprehensive company report
Eshyasi Pharma Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Eshyasi Pharma operates one associated brand: Eshyasi Pharma Limited. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Manufacturing of active pharmaceutical ingredients and intermediates in the pharmaceuticals sector. | eshyasi.com |
Business activity
The main business activities of Eshyasi Pharma are manufacturing and support service to organizations. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products and other support services to organizations. 2 activity segments are registered with the MCA.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | |
| N | Support service to Organizations | N7 | Other support services to organizations |
To see the full business activity and turnover split of Eshyasi Pharma Limited, buy the company report.
Financials of Eshyasi Pharma Limited
FY 2025 filings availableEshyasi Pharma Limited reported revenue of ₹3.66 Cr (down 7% YoY) for FY 2024.
Revenue · FY 2024
₹3.66 Cr ▼ 7%
Net profit · FY 2024
₹16.31 Lakh margin 4.5%
EBITDA · FY 2024
₹60.33 Lakh margin 16.5%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 7%
3 years · compounded
▼ 21%
5 years · compounded
▼ 9%
EBITDA CAGR growth
1 year
▲ 484%
3 years · compounded
▲ 3%
5 years · compounded
▲ 4%
Revenue has declined at a compounded annual rate (CAGR) of 9% over five years, including a 7% fall in the latest year. EBITDA rose 484% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹60.33 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹16.31 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 16.5% | ||||
| Net Profit Margin | 4.5% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Eshyasi Pharma Limited, buy the company report.
Board of directors of Eshyasi Pharma Limited
Eshyasi Pharma has 4 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Mahesh Natvarlal Shah | Whole-Time Director | 04 Feb 2008 | 18 Years 8 Months | Current |
| Monik Mahesh Shah | Whole-Time Director | 03 Oct 2008 | 18 Years 0 Months | Current |
| Shachi Monik Shah | Director | 04 Aug 2010 | 16 Years 2 Months | Current |
| Nisha Mahesh Shah | Director | 04 Aug 2010 | 16 Years 2 Months | Current |
Peer comparison
Eshyasi Pharma Limited is compared with the 6 companies closest to it by revenue in the Pharma industry (API Manufacturers, Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Arizest Pharma (India) Private Limited | ₹3.68 Cr (FY 2025) | 1.0% | Bengaluru, Karnataka, India | |||
| Prolife Fine and Specialty Chemicals Private Limited | ₹3.67 Cr (FY 2019) | Ahmedabad, Gujarat, India | ||||
| Vasoya Industries Private Limited | ₹3.66 Cr (FY 2025) | -59.0% | Surat, Gujarat, India | |||
| Eshyasi Pharma Limitedthis company | ₹3.66 Cr (FY 2024) | ₹16.31 Lakh | 4.5% | -7.0% | 2 | Vadodara, Gujarat, India |
| Ravi Plant Biotechnologies Limited | ₹3.66 Cr (FY 2025) | 21.0% | Panchmahals, Gujarat, India | |||
| Invision Pharma Limited | ₹3.66 Cr (FY 2024) | 29.0% | Bengaluru, Karnataka, India | |||
| All-Cure Pharma Private Limited | ₹3.65 Cr (FY 2024) | 5.0% | New Delhi, Delhi, India |
To see the full peer comparison of Eshyasi Pharma Limited, buy the company report.
Auditor
Eshyasi Pharma Limited is audited by S.M. Kabra & Co. for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| S.M. Kabra & Co. | FY 2023 | 112422 |
Shareholding
The shareholding of Eshyasi Pharma Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Eshyasi Pharma Limited, buy the company report.
Charges & borrowings
Open charges
₹15.69 Lakh
Satisfied charges
₹1.95 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 28 Nov 2023 | 100849272 | Hdfc Bank Limited | ₹7.53 Lakh | Open | |
| 22 Nov 2023 | 100849267 | Hdfc Bank Limited | ₹8.16 Lakh | Open | |
| 03 Jun 2016 | 100029899 | Hdfc Bank Limited | ₹1.95 Cr | Satisfied |
To see the full charge records of Eshyasi Pharma Limited, buy the company report.
Total charge records: 3 View all charges
Legal cases
Eshyasi Pharma Limited has 6 court cases on record: 4 filed by Eshyasi Pharma, 2 filed against it. 1 case is pending and 5 are disposed.
Total cases
6
Filed by the company
4
Filed against the company
2
Pending
1
Disposed
5
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 5 | 2 | 1 |
| High courts | 1 | 0 | 0 |
Cases on record (5 of 6)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court, GUJARAT | Special civil application | Filed by the company against Madhya Gujarat Vij Company Limited and 2 others | Disposed |
| District court, Vadodara, Gujarat | Court case (TMSUIT) | Filed against the company by Tonira Pharma Limited | Disposed |
| District court, Vadodara, Gujarat | Court case (SPCS) | Filed by the company against an individual | Pending |
| District court, Vadodara, Gujarat | Court case (CR EN) | Filed by the company against an individual | Disposed |
| District court, Vadodara, Gujarat | Court case (RCA) | Filed against the company by Tonira Pharma | Disposed |
To see the full case history of Eshyasi Pharma Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Eshyasi Pharma Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Eshyasi Pharma Limited has a workforce of 2 employees on its EPFO records as of Sep 17, 2024, across 1 active EPFO establishment.
Employee count
2
Active EPFO establishments
1
Employee growth
-50%
GST
Eshyasi Pharma has 2 GST registrations: 2 active.
Total GSTINs
2
Active
2
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 24AADCT0137D1ZY | Gujarat | Active | 01 Jul 2017 |
| 23AADCT0137D1Z0 | Madhya Pradesh | Active | 09 Apr 2024 |
To see the full GST registrations and return filing status of Eshyasi Pharma Limited, buy the company report.
Recent activity
Eshyasi Pharma Limited has 12 board changes on record since 2008: 8 appointments and 4 cessations. The latest: Diptiben Rajeshkumar Shah ceased to be Director on 31 Aug 2010.
AGM
Eshyasi Pharma Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Eshyasi Pharma Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Ahmedabad.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 7.53 Lakh with Charge ID 100849272 was registered on 28 Nov 2023.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 8.16 Lakh with Charge ID 100849267 was registered on 22 Nov 2023.
Charges
A charge registered on 03 Jun 2016 via Charge ID 100029899 with Hdfc Bank Limited was fully satisfied on 11 Oct 2021.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 195.00 Lakh with Charge ID 100029899 was registered on 03 Jun 2016.
Ceased
Diptiben Rajeshkumar Shah ceased to be Director.
Ceased
Maulinkumar Bhailal Shah ceased to be Director.
Appointed
Nisha Mahesh Shah was appointed as Director.
Ceased
Sasidharan Narayanan Nair ceased to be Additional Director.
Appointed
Shachi Monik Shah was appointed as Director.
Ceased
Ramniwas Parbhatilal Jangir ceased to be Additional Director.
7 earlier events are in the company report.
Frequently asked questions
Eshyasi Pharma is an active public limited company based in Vadodara, Gujarat, India. The company works in api manufacturers, within the pharma industry. It was incorporated on 04 February 2008 (18+ years old) and is registered under CIN U24232GJ2008PLC052796.
Eshyasi Pharma has 4 current directors:
- Mahesh Natvarlal Shah - Whole-Time Director
- Monik Mahesh Shah - Whole-Time Director
- Shachi Monik Shah - Director
- Nisha Mahesh Shah - Director
The latest financial statements of Eshyasi Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Eshyasi Pharma is 24AADCT0137D1ZY, registered in Gujarat. The company has 2 GST registrations in all, of which 2 are active. Other active GSTINs include 23AADCT0137D1Z0 (Madhya Pradesh).
The CIN (Corporate Identification Number) of Eshyasi Pharma is U24232GJ2008PLC052796. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Eshyasi Pharma has 6 court cases on record: 4 filed by the company and 2 filed against it. 1 is pending. Most are in the district courts.
Eshyasi Pharma was incorporated on 04 February 2008, making it 18+ years old. It is registered with the Registrar of Companies, Ahmedabad.
The peers of Eshyasi Pharma by revenue are Arizest Pharma (India) Private Limited, Prolife Fine and Specialty Chemicals Private Limited, Vasoya Industries Private Limited, Ravi Plant Biotechnologies Limited, Invision Pharma Limited and 1 more, all in the Pharma industry (API Manufacturers, Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Diptiben Rajeshkumar Shah ceased to be Director on 31 Aug 2010. Maulinkumar Bhailal Shah ceased to be Director on 31 Aug 2010. Nisha Mahesh Shah was appointed as Director on 04 Aug 2010. Eshyasi Pharma has 12 board changes on record in total.
Yes, Eshyasi Pharma is registered as a micro enterprise under Udyam registration (number: UDYAM-GJ-24-0011155).
Eshyasi Pharma can be reached through the website eshyasi.com. Its registered office is in Vadodara, Gujarat, India.